GSK Stock Ownership Activity

GLAXOSMITHKLINE PLC-SPON ADR 13F holders

1 value investing guru has made changes to the GLAXOSMITHKLINE PLC-SPON ADR (GSK) position according to the gurus' latest SEC quarterly report(s). The number of GSK shares has been decreased by 1 super investor(s).

Which gurus or hedge funds are buying GSK now?

According to the latest SEC filing(s) GLAXOSMITHKLINE PLC-SPON ADR (GSK) has not been purchased by any super investor.

To see more about who is investing in GLAXOSMITHKLINE PLC-SPON ADR (GSK), please go to the GSK ownership page.

History
Name
Company
%
Activity
Share
Change
% change to
Portfolio
% of
Portfolio
2024 Q3 (1 result)
Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group
-14.70%
-182,429
-1.28%
7.46%
Current price: $34.06 16.68% Reported price*: $40.88
2024 Q2 (1 result)
Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group
-0.99%
-12,383
-0.08%
8.03%
Current price: $34.06 11.53% Reported price*: $38.50
2024 Q1 (1 result)
Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group
-0.46%
-5,692
-0.04%
7.77%
Current price: $34.06 20.55% Reported price*: $42.87
2023 Q4 (1 result)
Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group
-1.78%
-22,807
-0.13%
7.35%
Current price: $34.06 8.10% Reported price*: $37.06
2023 Q3 (1 result)
Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group
+1.49%
+12,993
+0.11%
5.00%
Current price: $34.06 6.04% Reported price*: $36.25
2023 Q2 (1 result)
Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group
-1.10%
-14,018
-0.07%
6.60%
Current price: $34.06 4.43% Reported price*: $35.64
2023 Q1 (1 result)
Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group
+4.12%
+50,570
+0.26%
6.54%
Current price: $34.06 4.27% Reported price*: $35.58
2022 Q4 (2 results)
Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group
-5.98%
-78,033
-0.36%
5.68%
B. Tweedy, Ch. Browne
Tweedy, Browne Co All Funds (US)
-100.00%
-145,663
-0.23%
0.00%
Current price: $34.06 3.07% AVG reported price*: $35.14
2022 Q3 (4 results)
Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group
+13.98%
+160,011
+0.73%
5.98%
B. Tweedy, Ch. Browne
Tweedy, Browne Co All Funds (US)
-4.38%
-6,674
-0.01%
0.00%
V. D. Dodge, E. M. Cox
Dodge & Cox Stock Fund
-100.00%
-20,961,478
-2.87%
0.00%
Mark A. Hillman
Hillman Value Fund
-100.00%
-128,000
-3.87%
0.00%
Current price: $34.06 15.73% AVG reported price*: $29.43
2022 Q2 (4 results)
Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group
+0.32%
+3,111
+0.03%
7.26%
B. Tweedy, Ch. Browne
Tweedy, Browne Co All Funds (US)
-3.25%
-3,608
-0.01%
0.24%
V. D. Dodge, E. M. Cox
Dodge & Cox Stock Fund
-13.26%
-3,203,860
-0.41%
0.00%
Sarah Ketterer
Causeway Capital Management
-100.00%
-177,763
-0.28%
0.00%
Current price: $34.06 37.40% AVG reported price*: $54.41
2022 Q1 (3 results)
Sarah Ketterer
Causeway Capital Management
+44.71%
+54,923
+0.08%
0.00%
Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group
-0.83%
-9,524
-0.07%
7.89%
B. Tweedy, Ch. Browne
Tweedy, Browne Co All Funds (US)
-1.44%
-2,303
-0.00%
0.28%
Current price: $34.06 37.45% AVG reported price*: $54.45
2021 Q4 (5 results)
Sarah Ketterer
Causeway Capital Management
buy
+107,127
+0.17%
0.13%
B. Tweedy, Ch. Browne
Tweedy, Browne Co All Funds (US)
+7.53%
+11,185
+0.02%
0.28%
Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group
+6.30%
+53,853
+0.52%
6.88%
V. D. Dodge, E. M. Cox
Dodge & Cox Stock Fund
+0.72%
+337,520
+0.02%
2.73%
Jim Cullen
Cullen Value Fund
-100.00%
-11,040
-1.91%
0.00%
Current price: $34.06 38.21% AVG reported price*: $55.13
2021 Q3 (3 results)
Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group
+4.34%
+44,999
+0.30%
7.28%
V. D. Dodge, E. M. Cox
Dodge & Cox Stock Fund
+0.11%
+52,320
+0.00%
2.49%
B. Tweedy, Ch. Browne
Tweedy, Browne Co All Funds (US)
-1.69%
-2,149
-0.00%
0.20%
Current price: $34.06 28.69% AVG reported price*: $47.76
2021 Q2 (3 results)
Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group
+2.48%
+25,071
+0.18%
7.40%
V. D. Dodge, E. M. Cox
Dodge & Cox Stock Fund
+0.88%
+411,078
+0.02%
2.67%
B. Tweedy, Ch. Browne
Tweedy, Browne Co All Funds (US)
-1.96%
-3,027
-0.00%
0.21%
Current price: $34.06 31.57% AVG reported price*: $49.78
2021 Q1 (4 results)
Mark A. Hillman
Hillman Value Fund
buy
+120,320
+3.30%
3.11%
V. D. Dodge, E. M. Cox
Dodge & Cox Stock Fund
+40.46%
+13,417,940
+0.76%
2.64%
B. Tweedy, Ch. Browne
Tweedy, Browne Co All Funds (US)
+26.11%
+31,915
+0.04%
0.20%
Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group
-1.26%
-12,923
-0.09%
6.99%
Current price: $34.06 23.65% AVG reported price*: $44.61
2020 Q4 (4 results)
V. D. Dodge, E. M. Cox
Dodge & Cox Stock Fund
+42.54%
+9,898,400
+0.65%
2.17%
B. Tweedy, Ch. Browne
Tweedy, Browne Co All Funds (US)
-4.28%
-5,467
-0.01%
0.17%
Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group
-8.87%
-99,812
-0.80%
8.23%
Jim Cullen
Cullen Value Fund
-18.70%
-2,540
-0.47%
2.05%
Current price: $34.06 25.96% AVG reported price*: $46.00
2020 Q3 (3 results)
V. D. Dodge, E. M. Cox
Dodge & Cox Stock Fund
+11.49%
+1,918,272
+0.19%
1.45%
B. Tweedy, Ch. Browne
Tweedy, Browne Co All Funds (US)
+2.65%
+3,295
+0.01%
0.23%
Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group
-7.33%
-88,983
-0.79%
10.04%
Current price: $34.06 27.61% AVG reported price*: $47.05
2020 Q2 (3 results)
Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group
-1.66%
-20,560
-0.18%
10.51%
B. Tweedy, Ch. Browne
Tweedy, Browne Co All Funds (US)
-5.53%
-7,289
-0.01%
0.25%
V. D. Dodge, E. M. Cox
Dodge & Cox Stock Fund
-6.79%
-1,003,199
-0.13%
1.18%
Current price: $34.06 33.30% AVG reported price*: $51.07
2020 Q1 (3 results)
Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group
-2.77%
-35,208
-0.31%
10.70%
B. Tweedy, Ch. Browne
Tweedy, Browne Co All Funds (US)
-3.73%
-5,102
-0.01%
0.29%
V. D. Dodge, E. M. Cox
Dodge & Cox Stock Fund
-9.45%
-1,179,801
-0.22%
1.05%
Current price: $34.06 28.09% AVG reported price*: $47.36
48 of 122

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.